Allergy Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: Size, Share, Growth, Trends, and Global Industry Analysis By Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others), By Drug Treatment (Anti-Allergy Drugs and Immunotherapy), By Dosage Form (Oral, Inhalation, Intranasal, Others), By Distribution Channel (Hospital, Retail Pharmacy, Online Pharmacy, and Others), and Region Forecast 2019-2030

Allergy Treatment Market size was valued at US$ 24,725.6 million in 2023 and is expected to grow at a CAGR of 5.3% from 2024 - 2030.  The allergy treatment Market is fuelled by several key factors such as increasing allergy prevalence, advancements in treatments, awareness, and diagnosis. The allergy treatment market's rising due to growing numbers of patients with different forms of allergies, changing lifestyles, and environmental pollution are the main factors driving the global market for allergy treatment. Additionally, the market for allergy treatments is growing as a result of several factors, such as the rising number of people with various allergies, such as skin, asthma, rhinitis, and allergies to the eyes, the growing demand for advanced therapy for treating allergies, dietary changes, and an increase in research and development activities. Some restraints impact allergy treatment high costs, side effects, and limited access. During the projected period, major companies are working on research and development projects and creating novel treatments to treat severe allergies.

However, during the projected era, the introduction of new products with the endorsement of influential marketers is probably going to accelerate the expansion of the global allergy treatment market. Opportunities like emerging markets, biologics and personalized medicine, and digital health solutions, over the projected period of 2022–2029, the rising prevalence of asthma is expected to fuel the market's growth rate. Dietary allergies and asthma frequently coexist. When this occurs, there's a higher chance that the symptoms of food allergy and asthma may be severe. Additionally, the market for allergy treatments will grow due to increased awareness-raising efforts by both public and private groups. Furthermore, as people's lifestyles change and manufacturers continue to invest more in the creation of innovative allergy medicines, the market for allergy treatments will rise. The innovative launch of immunotherapy products is also expected to drive the segment during the forecast period.

Allergy Treatment Market Key Developments:

• In February 2024, the US Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in adults and children to treat allergic reactions (Type I) and reduce the risk of anaphylaxis reaction that could occur with accidental exposure to one or more food items. Hence, such product approvals are also expected to drive the growth of the segment during the forecast period.
• November 2023: The United States Food and Drug Administration approved fast-track designation for Alladapt Immunotherapeutic’ IgE-mediated multi-food oral immunotherapy, ADP101, based on Phase I/II data.